Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
minds.ai is an artificial intelligence company that leverages Deep Reinforcement Learning (DRL) to optimize complex industrial processes, with a significant focus on the life sciences and biomanufacturing sectors. The company's core offering, the DeepSim platform, enables the creation of digital twins and the application of DRL to automate and enhance bioreactor control and bioprocess development. By optimizing parameters such as nutrient feed and environmental conditions, minds.ai helps biotech organizations improve the yield and consistency of biologics and other therapeutic products. Their technology is designed to accelerate the transition from lab-scale simulation to full-scale production, reducing costs and development timelines. The company operates globally, providing scalable AI solutions that integrate with existing manufacturing hardware and software ecosystems. Through its collaboration with industry leaders, minds.ai continues to bridge the gap between advanced AI research and practical industrial deployment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on minds.ai.